FDA

House Committee Hearing Discusses FDA’s Shortcomings, Priorities of Supply Over Safety

The expert witness testimony made it clear that U.S. labs were treated differently than foreign ones, and despite increases in hiring at the FDA over the years, lawmakers have a lot to be concerned about when it comes to the FDA conducting proper oversight of foreign manufacturing facilities.

Details
Solar panels

Solar Tariffs Were Supposed to Ruin the Solar Business. They Didn’t, ITC Concludes.

Section 201 solar safeguard tariffs were supposed to ruin the solar business and completely stall deployment of solar on rooftops and vacant fields controlled by electric utility companies. But according to a U.S. government report, they did nothing of the sort.

Details
Ways & Means: Drug Shortages

House Ways & Means Discusses Solutions To Drug Shortages, Foreign Lab Dependence

According to expert testimony given by the witnesses, the crisis is being fueled by poor manufacturing practices that have led to recalls by foreign drug manufacturers, and the race to the bottom on generic drug prices that make it impossible for American generic drug makers to compete with subsidized competitors in India and China.

Details